Effects of Ethanol Extract of Ligularia fischeri Leaves on Freund's Complete Adjuvant-Induced Model of Chronic Arthritis in Mice

  • Choi, Eun-Mi (Department of Food & Nutrition, Kyung Hee University)
  • Published : 2006.04.30

Abstract

The aim of this study was to investigate the anti-inflammatory and anti-oxidant activity of Ligularia fischeri leaf extract on adjuvant induced arthritis in experimental mice. The oral administration of the L. fischeri leaf extract (LF), at doses of 100 and 200 mg/kg body weight once a day for 3 weeks, significantly reduced hindpaw swelling and the production of inflammatory cytokines (tumor necrosis factor(TNF)-${\alpha}$, interleukin(IL)-$1{\beta}$, and IL-6). Treatment with LF (100 mg/kg) also decreased the serum levels of triglyceride and low density lipoprotein(LDL)-cholesterol, and increased high density lipoprotein(HDL)-cholesterol contents compared with those of a control group. The induction of arthritis significantly increased oxidized proteins such as protein carbonyl, advanced oxidation protein products, and advanced glycation end-products in the lung, heart, and brain. Treatment with LF for 3 weeks reduced the levels of oxidized proteins. These results suggest that L. fischeri extract might be beneficial in the treatment of chronic inflammatory disorders.

Keywords

References

  1. Gauldie SD, McQueen DS, Clarke CJ, Chessell IP. A robust model of adjuvant-induced chronic unilateral arthritis in two mouse strains. J. Neurosci. Meth. 139: 281-291(2004) https://doi.org/10.1016/j.jneumeth.2004.05.003
  2. Hang L, Theofilopoulus AN, Dixon FJ. A spontaneous rheumatoid arthritis-like disease in MRL/l mice. J. Exp. Med. 155: 1690-1692 (1982) https://doi.org/10.1084/jem.155.6.1690
  3. Silvan AM, Abad MJ, Bermejo P, Villar AM. Adjuvant-carrageenaninduced inflammation in mice. Gen. Pharmacol. 29: 665-669 (1997) https://doi.org/10.1016/S0306-3623(96)00561-7
  4. Choi EM, Lee KH, Koo SJ. Effects of Ethanol Extract of Potato (Solanum tuberiosum) on Freund's Complete Adjuvant-induced Model of Chronic Arthritis in Mice. Food Sci. Biotechnol. 14: 228232 (2005)
  5. Maziere C, Auclair M, Maziere JC. Tumor necrosis factor enhances low density lipoprotein oxidative modification by monocytes and endothelial cells. FEBS Lett. 338: 43-46 (1994) https://doi.org/10.1016/0014-5793(94)80113-4
  6. Chajek-Shaul T, Friedman G, Stein O. Mechanism of the hypertriglyceridemia induced by tumor necrosis factor administration to rats. Biochim. Biophys. Acta 1001: 316--324 (1989) https://doi.org/10.1016/0005-2760(89)90116-1
  7. Srinivasan K, Muruganandan S, Lal J, Chandea S, Tandan SK, Prakash VR. Evaluation of anti-inflammatory activity of Pongamia pinnata leaves in rats. J. Ethnopharmacol. 78: 151-157 (2001) https://doi.org/10.1016/S0378-8741(01)00333-6
  8. Kim AJ, Yuh JS, Kim SY, Park SJ, Sung CJ. Anti-inflammatory Effect of the Ostrich Extract Combined with Korean Herbal Medicine. Food Sci. Biotechnol. 13: 472-475 (2004)
  9. Choi OJ. Usage and constituents of medicinal plants. Seoul, Korea. Iweolseogak, p. 621 (1991)
  10. Lee KT, Koo SJ, Jung SH, Choi J, Jung HJ, Park HJ. Structure of three new terpenoids, spiciformisins a and b, and monocyclosqualene, isolated from the herbs of Ligularia fischeri var. spiciformis and cytotoxicity. Arch. Pharm. Res. 25: 820-823 (2002) https://doi.org/10.1007/BF02976998
  11. Choi J, Park JK, Lee KT, Park KK, Kim WB, Lee JH, Jung HJ, Park HJ. In vivo antihepatotoxic effects of Ligularia fischeri var. spiciformis and the identification of the active component, 3,4dicaffeoylquinic acid. J. Med. Food 8: 348-352 (2005) https://doi.org/10.1089/jmf.2005.8.348
  12. Park HJ, Kwon SH, Yoo KO, Sohn lC, Lee KT. Sesquiterpenes from the leaves of Ligularia jischeri var. spiciformis. Planta Med. 66: 783-784 (2000) https://doi.org/10.1055/s-2000-9602
  13. Jeong SH, Koo SJ, Choi JH, Park JH, Ha JH, Park HJ, Lee KT. Intermedeol isolated from the leaves of Ligularia jischeri var. spiciformis induces the differentiation of human acute promyeocytic leukemiaHL-60 cells. Planta Med. 68: 881-885 (2002) https://doi.org/10.1055/s-2002-34932
  14. Corsi MM, Fulgenzi A, Tiengo M, Pravettoni G, Gaja G, Ferrero ME. Effect of somatostatin on $\beta$-endorphin release in rat experimental chronic inflammation. Life Sci. 64: 2247-2254 (1999) https://doi.org/10.1016/S0024-3205(99)00176-9
  15. Hong H, Johnson P. Antioxidant enzyme activities and lipid peroxidation levels in exercised and hypertensive rat tissues. Int J Biochem. Cell BioI. 27: 923-931 (1995) https://doi.org/10.1016/1357-2725(95)00057-V
  16. Tietz NW (ed.). Textbook of clinical chemistry. WB Com. PA, USA (1986)
  17. Fagan JM, Sleczka BG, Sohar J. Quantification of oxidative damage to tissue proteins. Int. J. Biochemi. Cell BioI. 31: 751-757 (1999) https://doi.org/10.1016/S1357-2725(99)00034-5
  18. Johnson GD. Correlation of color and constitution. 1. 2,4-dinitrophenylhydrozones. J. Am. Chem. Soc. 75: 2720-2723 (1953) https://doi.org/10.1021/ja01107a051
  19. Witko V, Nguyen AT, Descamps-Latscha B. Microtiter plate assay for phagocyte-derived taurine-chloramines. J. Clin. Lab. Anal. 6: 4753 (1992) https://doi.org/10.1002/jcla.1860060110
  20. Kalousava M, Zima T, Tesar V, Lachmanova J. Advanced glycation end products and advanced oxidation protein products in hemodialyzed patients. Blood Purifieat. 20: 531-536 (2002) https://doi.org/10.1159/000066956
  21. Gupta M, Mazumdar UK, Sivakumar T, Vamsi ML, Karki SS, Sambathkumar R, Manikandan L. Evaluation of anti-inflammatory activity of chloroform extract of Bryonia laciniosa in experimental animal models. BioI. Pharm. Bull. 26: 1342-B44 (2003) https://doi.org/10.1248/bpb.26.1342
  22. Theze J. The cytokine networks and immune functions. Oxford University Press. Oxford, UK p. 373 (1999)
  23. Cannon JG.Inflammatory cytokines in nonpathological states. News Physiol. Sci. 15: 298-303 (2000)
  24. Elenkov IJ, Chrousos GP. Stress, cytokine patterns and susceptibility to disease. Bailliere's best practice & research. Clin. Endocrinol. Metab. 13: 583-595 (1999)
  25. Sironi M, Gadina M, Kankova M, Riganti F, Mantovani A, Zandalasini M, Ghezzi P. Differential sensitivity of in vivo TNF and IL-6 production to modulation by anti-inflammatory drugs in mice. Int. J. Immunopharmacol. 14: 1045-1050 (1992) https://doi.org/10.1016/0192-0561(92)90149-F
  26. Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265: 956-959 (1994) https://doi.org/10.1126/science.8052854
  27. Navab M, Imes SS, Hough GP. Monocyte transmigration induced by modification of LDL in cocultures of human aortic wall cells is due to induction of MCP 1 synthesis and is abolished by HDL. J. Clin. Invest 88: 2039-2046 (1991) https://doi.org/10.1172/JCI115532
  28. Cockerill GW, Rye K, Gamble JR. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscl. Throm. Vas. 15: 1987-1994 (1995) https://doi.org/10.1161/01.ATV.15.11.1987
  29. Klimov AN, Popov AV, Nagomev VA. Effect of high density lipoproteins on permeability of rabbit aorta to low density lipoproteins. Atherosclerosis 55: 217-223 (1985) https://doi.org/10.1016/0021-9150(85)90100-5
  30. Jimenez I, Lissi E, Speisky H: Free radical-induced inactivation of lysozyme and carbonyl residue generation in protein are not necessarily associated. Arch. Biochem. Biophys. 381: 247-52 (2000) https://doi.org/10.1006/abbi.2000.1963
  31. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 329: 23-38 (2003) https://doi.org/10.1016/S0009-8981(03)00003-2
  32. Lampert MB,Weiss SJ. The chlorinating potential of the human monocyte. Blood 62: 645-651 (1983)
  33. Witko-Sarsat V, Friedlander M, Khoa NT, Blandin C, Nguyen AT, Canteloup S. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. Immunology 161: 2524-2532 (1998)
  34. Singh, R., Barden, A., Mori, T., Beilin, L., Advanced glycation endproducts: a review. Diabetologia 44: 129-146 (2001) https://doi.org/10.1007/s001250051591
  35. Miyata M, lida Y, Horie K, Cai Z, Sugiyama S, Maeda K. Pathophysiology of advanced glycation end-products in renal failure. Nephrol. Dial. Transpl. 11: 27-80 (1996) https://doi.org/10.1093/ndt/11.supp5.27
  36. Takagi M, Kasayama S, Yamamoto T. Advanced glycation end products stimulate interleukin 6 production by human bone derived cells. J. Bone Miner. Res. 12: 439-46 (1997) https://doi.org/10.1359/jbmr.1997.12.3.439
  37. Isomaki P, Punnonen J. Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann. Med. 29: 499-550 (1997) https://doi.org/10.3109/07853899709007474